ActiveGRANT

DoW Amyotrophic Lateral Sclerosis Research Program, Pilot Clinical Trial Award

Department of DefenseDept. of the Army -- USAMRAA

AI Overview

This DoD funding supports rapid clinical trials testing new ALS treatments, from phase 1 through small phase 2 studies. Focus areas include biomarker-driven interventions and improved clinical care approaches for managing the disease.

This summary is AI-generated from the official solicitation.

Key Details

Agency
Department of Defense
Funding Amount
—
Release Date
May 4, 2026
Due Date
September 30, 2026

Official Description

<p><strong>Summary: </strong>The fiscal year 2026 (FY26) Amyotrophic Lateral Sclerosis Research Program (ALSRP) Pilot Clinical Trial Award (PCTA) supports the rapid implementation of clinical trials with the potential to have a significant impact on the treatment or management of amyotrophic lateral sclerosis (ALS). Projects may range from phase 1 to small-scale phase 2 trials.</p><p><br></p><p>Applications must address one of the following focus areas:</p><p><br></p><p>·&nbsp;&nbsp;&nbsp;&nbsp;...
View on official source

Change History

Opportunity AddedMay 4, 2026 at 1:45 PM

DoW Amyotrophic Lateral Sclerosis Research Program, Pilot Clinical Trial Award

New Grants.gov opportunity: DoW Amyotrophic Lateral Sclerosis Research Program, Pilot Clinical Trial Award

Get Alerts for Opportunities Like This

RallyProp monitors thousands of funding sources and sends instant alerts when opportunities match your technology and capabilities.

Start Free Trial